Nodular lymphocyte-predominant hodgkin lymphoma

Dennis A. Eichenauer; Michelle A. Fanale

doi:10.1007/978-3-319-12505-3_16

Nodular lymphocyte-predominant hodgkin lymphoma

Dennis A. Eichenauer, Michelle A. Fanale

Lymphoma-Myeloma

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare lymphoma entity representing about 5 % of all HL cases. Pathobiology and clinical course substantially differ from classical HL (cHL). This chapter describes the pathologic and clinical characteristics, differential diagnoses, risk factors, and treatment options of NLPHL.

Original language	English (US)
Title of host publication	Hodgkin Lymphoma
Subtitle of host publication	A Comprehensive Overview, Second Edition
Publisher	Springer International Publishing
Pages	287-295
Number of pages	9
ISBN (Electronic)	9783319125053
ISBN (Print)	9783319125046
DOIs	https://doi.org/10.1007/978-3-319-12505-3_16
State	Published - Jan 1 2015

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-3-319-12505-3_16

Cite this

@inbook{88ae9befaaf542078d9e6c5ac650eab3,

title = "Nodular lymphocyte-predominant hodgkin lymphoma",

abstract = "Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare lymphoma entity representing about 5 % of all HL cases. Pathobiology and clinical course substantially differ from classical HL (cHL). This chapter describes the pathologic and clinical characteristics, differential diagnoses, risk factors, and treatment options of NLPHL.",

author = "Eichenauer, {Dennis A.} and Fanale, {Michelle A.}",

note = "Publisher Copyright: {\textcopyright} Springer International Publishing Switzerland 2015.",

year = "2015",

month = jan,

day = "1",

doi = "10.1007/978-3-319-12505-3_16",

language = "English (US)",

isbn = "9783319125046",

pages = "287--295",

booktitle = "Hodgkin Lymphoma",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Nodular lymphocyte-predominant hodgkin lymphoma

AU - Eichenauer, Dennis A.

AU - Fanale, Michelle A.

N1 - Publisher Copyright: © Springer International Publishing Switzerland 2015.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare lymphoma entity representing about 5 % of all HL cases. Pathobiology and clinical course substantially differ from classical HL (cHL). This chapter describes the pathologic and clinical characteristics, differential diagnoses, risk factors, and treatment options of NLPHL.

AB - Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare lymphoma entity representing about 5 % of all HL cases. Pathobiology and clinical course substantially differ from classical HL (cHL). This chapter describes the pathologic and clinical characteristics, differential diagnoses, risk factors, and treatment options of NLPHL.

UR - http://www.scopus.com/inward/record.url?scp=84955663761&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955663761&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-12505-3_16

DO - 10.1007/978-3-319-12505-3_16

M3 - Chapter

AN - SCOPUS:84955663761

SN - 9783319125046

SP - 287

EP - 295

BT - Hodgkin Lymphoma

PB - Springer International Publishing

ER -

Nodular lymphocyte-predominant hodgkin lymphoma

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this